178 related articles for article (PubMed ID: 23815912)
1. [Autoimmune hemolytic anemia associated with B-cell chronic lymphoproliferative disorders].
Zhuang Y; Fan L; Shen YF; Xu W; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):633-6. PubMed ID: 23815912
[TBL] [Abstract][Full Text] [Related]
2. Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia.
D'Arena G; Laurenti L; Capalbo S; D'Arco AM; De Filippi R; Marcacci G; Di Renzo N; Storti S; Califano C; Vigliotti ML; Tarnani M; Ferrara F; Pinto A
Am J Hematol; 2006 Aug; 81(8):598-602. PubMed ID: 16823816
[TBL] [Abstract][Full Text] [Related]
3. Bendamustine and rituximab combination in the management of chronic lymphocytic leukemia-associated autoimmune hemolytic anemia: a multicentric retrospective study of the French CLL intergroup (GCFLLC/MW and GOELAMS).
Quinquenel A; Willekens C; Dupuis J; Royer B; Ysebaert L; De Guibert S; Michallet AS; Feugier P; Guieze R; Levy V; Delmer A
Am J Hematol; 2015 Mar; 90(3):204-7. PubMed ID: 25428829
[TBL] [Abstract][Full Text] [Related]
4. [Successful treatment with rituximab for autoimmune hemolytic anemia associated with chronic lymphocytic leukemia].
Tanaka Y; Ito Y; Yoshizawa S; Fujimoto H; Gotoh M; Tauchi T; Kimura Y; Ohyashiki K
Rinsho Ketsueki; 2013 Feb; 54(2):229-31. PubMed ID: 23470833
[TBL] [Abstract][Full Text] [Related]
5. The successful treatment of refractory autoimmune hemolytic anemia with rituximab in a patient with chronic lymphocytic leukemia.
Pamuk GE; Turgut B; Demir M; Tezcan F; Vural O
Am J Hematol; 2006 Aug; 81(8):631-3. PubMed ID: 16906592
[TBL] [Abstract][Full Text] [Related]
6. Rituximab-based chemotherapy for steroid-refractory autoimmune hemolytic anemia of chronic lymphocytic leukemia.
Gupta N; Kavuru S; Patel D; Janson D; Driscoll N; Ahmed S; Rai KR
Leukemia; 2002 Oct; 16(10):2092-5. PubMed ID: 12357362
[TBL] [Abstract][Full Text] [Related]
7. Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab (humanized CD52 monoclonal antibody).
Karlsson C; Hansson L; Celsing F; Lundin J
Leukemia; 2007 Mar; 21(3):511-4. PubMed ID: 17215854
[TBL] [Abstract][Full Text] [Related]
8. Fludarabine-associated autoimmune hemolytic anemia occurring in B-cell chronic lymphocytic leukemia.
Nishida H; Murase T; Ueno H; Park JW; Yano T; Ikeda Y
Leuk Res; 2006 Dec; 30(12):1589-90. PubMed ID: 16542723
[TBL] [Abstract][Full Text] [Related]
9. Prompt and sustained response of a steroid-refractory autoimmune hemolytic anemia to a rituximab-based therapy in a chronic lymphocytic leukemia patient.
Gentile M; Lucia E; Iorio C; Vigna E; Mazzone C; Morelli R; Bisconte MG; Gentile C; Morabito F
Cancer Chemother Pharmacol; 2008 Sep; 62(4):741-3. PubMed ID: 18064461
[TBL] [Abstract][Full Text] [Related]
10. Incipient Coombs' test negative autoimmune hemolytic anemia precedes non-Hodgkin's lymphoma.
Wan SG; Lin Y; Xia CQ; Zhao H; Xu J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Feb; 20(1):97-9. PubMed ID: 22391174
[TBL] [Abstract][Full Text] [Related]
11. Rituximab-cyclophosphamide-dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia.
Rossignol J; Michallet AS; Oberic L; Picard M; Garon A; Willekens C; Dulery R; Leleu X; Cazin B; Ysebaert L
Leukemia; 2011 Mar; 25(3):473-8. PubMed ID: 21127498
[TBL] [Abstract][Full Text] [Related]
12. Clinical and serological characterization of autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation.
Yang Z; Wu B; Zhou Y; Wang W; Chen S; Sun A; Wu D; Xu Y
Chin Med J (Engl); 2014; 127(7):1235-8. PubMed ID: 24709172
[TBL] [Abstract][Full Text] [Related]
13. A combination of rituximab, cyclophosphamide and dexamethasone effectively treats immune cytopenias of chronic lymphocytic leukemia.
Kaufman M; Limaye SA; Driscoll N; Johnson C; Caramanica A; Lebowicz Y; Patel D; Kohn N; Rai K
Leuk Lymphoma; 2009 Jun; 50(6):892-9. PubMed ID: 19391041
[TBL] [Abstract][Full Text] [Related]
14. Fludarabine-induced hemolytic anemia: successful treatment by rituximab.
Paydas S
Hematol J; 2004; 5(1):81-3. PubMed ID: 14745435
[TBL] [Abstract][Full Text] [Related]
15. [Clinical Features and Outcomes of the Patients with B-Cell Chronic Lymphoproliferative Disease in the New Drug Era].
Xu CB; Hu M; Shen JZ; Xu HQ; Zheng RJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):722-729. PubMed ID: 37356932
[TBL] [Abstract][Full Text] [Related]
16. [Are intravenous immunoglobulins useful in severe episodes of autoimmune hemolytic anemia?: Comparative results in 21 episodes from a single centre].
Gil-Fernández JJ; Flores Ballester E; González Martínez M; Arévalo-Serrano J; Tamayo Martín AT; Burgaleta Alonso de Ozalla C
Med Clin (Barc); 2013 Sep; 141(5):201-4. PubMed ID: 22857805
[TBL] [Abstract][Full Text] [Related]
17. Chronic lymphocytic leukemia-associated autoimmune hemolytic anemia.
D'Arena G; Cascavilla N
Leuk Lymphoma; 2007 Jun; 48(6):1072-80. PubMed ID: 17577769
[TBL] [Abstract][Full Text] [Related]
18. Ofatumumab in rituximab-refractory autoimmune hemolytic anemia associated with chronic lymphocytic leukemia: a case report and review of literature.
Nader K; Patel M; Ferber A
Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):511-3. PubMed ID: 23726016
[No Abstract] [Full Text] [Related]
19. Ibrutinib in combination with rituximab is highly effective in treatment of chronic lymphocytic leukemia patients with steroid refractory and relapsed autoimmune cytopenias.
Nikitin E; Kislova M; Morozov D; Belyakova V; Suvorova A; Sveshnikova J; Vyscub G; Matveeva I; Shirokova M; Shipaeva A; Klitochenko T; Makarovskaya P; Dmitrieva E; Biderman B; Sudarikov A; Obukhova T; Samoilova O; Kaplanov K; Konstantinova T; Mayorova O; Poddubnaya I; Ptushkin V
Leukemia; 2023 Jul; 37(7):1464-1473. PubMed ID: 37202442
[TBL] [Abstract][Full Text] [Related]
20. [Progress in diagnosis and treatment of autoimmune hemolytic disorders].
Kamesaki T
Rinsho Ketsueki; 2017; 58(4):329-335. PubMed ID: 28484163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
